AnaptysBio, Inc. ANAB
46.91 USD -1.37 -2.84%
At close · Nov 2
46.91 0.00 0.00%
After hours · Nov 2, 4:23 PM ET
20.18 52-week range 72.36
- YTD
- +45.14%
- 1 year
- +92.33%
- Open
- 48.33
- Prev close
- 48.28
- Mkt cap
- 1.40B
- Vol
- 281.49K
- Avg vol
- 486.41K
- EPS
- -0.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 46.90
- High
- 48.37
- Forward P/E
- 10.34
- Beta
- 0.37
- Short ratio
- 9.41
- Inst. own
- 105.65%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 51.76
- 200-d avg
- 50.40
- 1y target
- 87.25
MAX chart
Chart tools
Chart is warming up
The all-time price history for ANAB has not been loaded yet. Try again in a moment.
Altman Z-Score
2.29 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 1
P/E -70.3×
P/S 3.8×
P/B 24.1×
P/FCF 45.8×
EV/EBITDA 9.7×
EV/Sales 2.9×
FCF Yield 2.2%
Gross Margin 99.0%
Operating Margin 20.4%
Net Margin -5.6%
ROE -35.6%
ROIC 14.6%
ROA -3.6%
Revenue 157.0%
Operating Income 141.7%
EPS (diluted) 91.0%
Free Cash Flow 114.5%
Current Ratio 9.1×
Quick Ratio 9.1×
Debt / Equity 0.4×
Net Debt / EBITDA -3.2×
Interest Coverage 0.6×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31